⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BIIB

Biogen Inc.

Healthcare · Drug Manufacturers - General

210.73USD

-1.7700 (-0.83%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 210.73
P/E22.7
Dvd Ind Yld—
P/B1.67
P/S3.1
Curr EV/T12M EBITDA13.3
Mkt Cap (USD)31.1B
Curr EV (USD)38.2B
2)

Per Share Data

EPS T12M9.32
DPS—
Bk Val Per Sh127.61
Rev/Sh66.96
Cash/Sh8.70
Curr Shares Out147.8M
FCF/Sh16.33
3)

Cash Flow Analysis

P/CF12.0
Curr P/FCF12.9
CF/NI1.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales26.1%
Eff Interest Rate5.1%
4)

Growth Potential

Dil EPS 1Y Gr-21.4%
Cap 1Y Gr6.7%
BPS 1Y Gr8.3%
R&D To Sales12.7%
Retention Rate100.0%
Rev 1Y Gr2.2%
FCF 1Y Gr-24.7%
Assets 1Y Gr5.0%
5)

Profitability

EBITDA2.9B
EBIT2.5B
Operating Margin24.9%
Pretax Margin16.3%
Net Margin13.8%
ROA4.8%
ROE7.7%
ROC8.4%
Asset Turnover0.35
6)

Structure

Current Ratio3.06
Quick Ratio0.94
Debt/Assets21.3%
Debt/Com Eq33.7%
Net Debt/EBITDA1.17
Tot Debt/Capital25.2%
Gross Margin75.5%
EBIT/Int Exp9.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.